Search Results - "Zong, Alice"
-
1
Development of a quantitative relationship between CAR-affinity, antigen abundance, tumor cell depletion and CAR-T cell expansion using a multiscale systems PK-PD model
Published in mAbs (01-01-2020)“…The development of mechanism-based, multiscale pharmacokinetic-pharmacodynamic (PK-PD) models for chimeric antigen receptor (CAR)-T cells is needed to enable…”
Get full text
Journal Article -
2
Bench‐to‐bedside translation of chimeric antigen receptor (CAR) T cells using a multiscale systems pharmacokinetic‐pharmacodynamic model: A case study with anti‐BCMA CAR‐T
Published in CPT: pharmacometrics and systems pharmacology (01-04-2021)“…Despite tremendous success of chimeric antigen receptor (CAR) T cell therapy in clinical oncology, the dose‐exposure‐response relationship of CAR‐T cells in…”
Get full text
Journal Article -
3
Data standards for model-informed drug development: an ISoP initiative
Published in Journal of pharmacokinetics and pharmacodynamics (01-10-2018)Get full text
Journal Article -
4
Data standards for model-informed drug development: an ISoP initiative
Published in Journal of pharmacokinetics and pharmacodynamics (01-10-2018)Get full text
Journal Article -
5
Predictors of nocturnal heartburn (NH) in a large population-based study
Published in Gastroenterology (New York, N.Y. 1943) (01-04-2003)Get full text
Journal Article -
6
Complications of ganciclovir implant surgery in patients with cytomegalovirus retinitis: the Ganciclovir Cidofovir Cytomegalovirus Retinitis Trial
Published in Retina (Philadelphia, Pa.) (01-02-2004)“…To describe the complications of ganciclovir implant surgery in patients with cytomegalovirus retinitis. Prospective data collection within the context of a…”
Get full text
Journal Article -
7
Development of a quantitative relationship between CAR-affinity, antigen abundance, tumor cell depletion and CAR-T cell expansion using a multiscale systems PK-PD model
Published in mAbs (01-01-2020)“…The development of mechanism-based, multiscale pharmacokinetic-pharmacodynamic (PK-PD) models for chimeric antigen receptor (CAR)-T cells is needed to enable…”
Get full text
Report